Zhongnan Medical Journal Press

Home Results

A total of 18 result was found. Results that relate to ZENG Xiantao

Research on evidence-based social intervention guidelines and standards Ⅰ: developing standards based on evidence-based concepts

Published on New Medicine 2024,34(1):53-63.
6181 times 1924 times

BAI Zhenggang ZHU Yumeng1 CHEN Hao GAI Qiongyan ZENG Xiantao SHI Nannan Campbell China Network

Evidence-based principle Standard Methodology
Details
Research progress on the mechanism of long non-coding RNA LINC00641 in the development of malignant tumors

Published on New Medicine 2024,34(1):88-98.
6580 times 1756 times

GUO Mengmeng MING Daojing REN Yiming QIAN Xinhang YANG Shisong WANG Congcong LU Peiwen ZHANG Jinhui YUAN Shuai XI Shu ZENG Xiantao

Long non-coding RNAs LINC00641 Malignant tumor
Details
Mechanism research of PI3K/AKT pathway regulating PHF19 gene expression in prostate cancer

Published on New Medicine 2024,34(2):121-128.
6114 times 2636 times

MING Daojing GUO Mengmeng ZHANG Jinhui LIU Mengyang SHI Minghui LIU Shuyan YUAN Shuai ZENG Xiantao

PI3K/AKT TP63 PHF19 Prostate cancer
Details
The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia

Published on New Medicine 2024,34(2):206-216.
7711 times 3588 times

QIAN Xinhang GU Jiamin LU Peiwen YANG Shisong FANG Cheng LI Xiaodong ZENG Xiantao

Benign prostatic hyperplasia Biomarkers Multi-omics analysis Aging
Details
Transurethral plasmakinetic resection of prostate in high-risk benign prostatic hyperplasia patients: a multicenter prospective study

Published on New Medicine 2024,34(4):381-390.
7786 times 2558 times

LI Fei GENG Jie CHEN Hongbo ZHOU Zhijun LIU Xiaohua SHI Hongbo DU Dan ZHU Tao ZHANG Jingyu LI Xiaodong QUE Hui SONG Hongfei YAO Qisheng DOU Zhongling RUAN Jianzhong ZHENG Jiang ZHU Ziqing REN Xuanyi HUANG Qiao GONG Kan LIU Tongzu HE Dalin ZENG Xiantao

Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia High-risk patients Cardiovascular diseases
Details
Research on evidence-based social intervention guidelines and standards Ⅲ: promote the scientific implementation of standards based on evidence-based principles

Published on New Medicine 2024,34(4):438-447.
7605 times 2363 times

ZHU Yumeng 2 GAI Qiongyan CHEN Hao ZENG Xiantao SHI Nannan GAO Xiangyu BAI Zhenggang Campbell China Network

Evidence-based principles Standard implementation Implementation science
Details
Consistency of ultrasonography and magnetic resonance imaging in measuring prostate size and volume

Published on New Medicine 2024,34(5):530-537.
7536 times 2089 times

MAO Xiaoli ZI Hao ZHANG Jie LIU Shuangtai HUANG Qiao LI Binghui ZENG Xiantao

Benign prostatic hyperplasia Prostate Size Volume Ultrasonography Magnetic resonance imaging Consistency
Details
Relationship and potential mechanisms between gut microbiota and benign prostatic hyperplasia

Published on New Medicine 2024,34(5):582-592.
7464 times 1794 times

WANG Congcong ZHANG Jie GUO Mengmeng LI Luyao ZENG Xiantao ZHANG Yuanyuan WANG Shuangying QIN Changjiang

Gut microbiota Benign prostatic hyperplasia Sex hormones Inflammation Metabolic disorders
Details
Definition and literature of evidence-based urology: a systematic review

Published on New Medicine 2024,34(7):725-743.
6555 times 1619 times

WANG Yunyun CHEN Zheng ZHONG Quliang HUANG Xing XU Xiaofeng LI Xiaodong ZI Hao JIN Yinghui LI Binghui WENG Hong DONG Zhilong ZENG Xiantao

Evidence-based medicine Evidence-based urology Definition Methodology Systematic review
Details
The effect of applying Bloom’s taxonomy theory of education in the teaching of evidence-based medicine curriculum for undergraduates

Published on New Medicine 2024,34(10):1183-1190.
6464 times 1538 times

WANG Yunyun YUAN Shuai WANG Yu LI Binghui FANG Cheng ZHANG Yuanyuan HUANG Jiao ZENG Xiantao

Bloom's taxonomy of educational objective Evidence-based medicine Teaching reform Application effect Teaching satisfaction
Details
The analysis of disease burden of benign prostatic hyperplasia in China from 1990 to 2021

Published on New Medicine 2024,34(12):1329-1336.
7987 times 1722 times

HU Yan WANG Xin CHEN Xianyan ZI Hao ZHU Cong FANG Cheng ZHAO Yongwei ZENG Xiantao

Benign prostatic hyperplasia Disease burden Incidence Prevalence Disability-adjusted life years
Details
Methodology for evidence-based urology——evidence classification and retrieval

Published on New Medicine 2025,35(1):2-13.
6877 times 1360 times

WANG Yunyun QIN Changjiang TONG Tiejun MA Bin CAO Shiyi ZHANG Chao REN Xuequn LI Xiaodong ZHANG Miao WENG Hong WANG Yang JIN Yinghui YANG Lu ZENG Xiantao

Evidence-based urology Evidence-based medicine Methodology Evidence Evidence classification Evidence retrieval
Details
Associations among immunophenotype, plasma metabolites, and benign prostatic hyperplasia: a mediation Mendelian randomization study

Published on New Medicine 2025,35(1):73-82.
4956 times 1090 times

FAN Jiuming ZHAO Yiqiao JIA Haichang WANG Tiankun HAN Yutong QI Zihao CHEN Ping ZENG Xiantao

Benign prostatic hyperplasia Mendelian randomization Immunophenotypes Plasma metabolites Exposure-mediator-outcome pathway Mediation analysis
Details
Effects of KCNN4 on the biological functions of prostate cancer cells

Published on New Medicine 2025,35(2):168-174.
4730 times 1249 times

WANG Danqi XI Shu CUI Jinlong WANG Shichun ZHANG Jia SHI Minghui YUAN Shuai ZENG Xiantao

KCNN4 Prostate cancer Ion channels Proliferation Migration
Details
The role and mechanism of GFPT2 in promoting the migration of prostate cancer cells

Published on New Medicine 2025,35(2):175-182.
5662 times 1328 times

CUI Jinlong XI Shu WANG Danqi SHI Minghui LIU Shuyan WANG Shichun LIU Guizi MING Daojing YUAN Shuai ZENG Xiantao

Prostate cancer GFPT2 O-GlcNAcylation Migration EMT
Details